Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

This study has been terminated.
(Corporate reasons unrelated to safety and efficacy)
Information provided by (Responsible Party):
Viventia Bio Identifier:
First received: May 31, 2007
Last updated: December 22, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)